Cite
HARVARD Citation
Weinblatt, M. et al. (n.d.). Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study1. Arthritis and rheumatism. 65 (1), pp. 28-38. [Online].